These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33403509)

  • 1. Novel insights on caffeine supplementation, CYP1A2 genotype, physiological responses and exercise performance.
    Barreto G; Grecco B; Merola P; Reis CEG; Gualano B; Saunders B
    Eur J Appl Physiol; 2021 Mar; 121(3):749-769. PubMed ID: 33403509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of
    Muñoz A; López-Samanes Á; Aguilar-Navarro M; Varillas-Delgado D; Rivilla-García J; Moreno-Pérez V; Del Coso J
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of CYP1A2 genotype on the ergogenic properties of caffeine during resistance exercise: a randomized, double-blind, placebo-controlled, crossover study.
    Rahimi R
    Ir J Med Sci; 2019 Feb; 188(1):337-345. PubMed ID: 29532291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does ergogenic effect of caffeine supplementation depend on CYP1A2 genotypes? A systematic review with meta-analysis.
    Wang J; Dewi L; Peng Y; Hou CW; Song Y; Condello G
    J Sport Health Sci; 2024 Jul; 13(4):499-508. PubMed ID: 38158179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: a systematic review.
    Grgic J; Pickering C; Del Coso J; Schoenfeld BJ; Mikulic P
    Eur J Nutr; 2021 Apr; 60(3):1181-1195. PubMed ID: 33137206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A2 Genotype Variations Do Not Modify the Benefits and Drawbacks of Caffeine during Exercise: A Pilot Study.
    Salinero JJ; Lara B; Ruiz-Vicente D; Areces F; Puente-Torres C; Gallo-Salazar C; Pascual T; Del Coso J
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28287486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance.
    Grgic J; Pickering C; Bishop DJ; Schoenfeld BJ; Mikulic P; Pedisic Z
    J Int Soc Sports Nutr; 2020 Apr; 17(1):21. PubMed ID: 32295624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine and 3-km cycling performance: Effects of mouth rinsing, genotype, and time of day.
    Pataky MW; Womack CJ; Saunders MJ; Goffe JL; D'Lugos AC; El-Sohemy A; Luden ND
    Scand J Med Sci Sports; 2016 Jun; 26(6):613-9. PubMed ID: 26062916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of CYP1A2 genotype in the blood pressure response to caffeine ingestion is affected by physical activity status and caffeine consumption level.
    Soares RN; Schneider A; Valle SC; Schenkel PC
    Vascul Pharmacol; 2018 Jul; 106():67-73. PubMed ID: 29522901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine improves various aspects of athletic performance in adolescents independent of their 163 C > A CYP1A2 genotypes.
    Spineli H; Pinto MP; Dos Santos BP; Lima-Silva AE; Bertuzzi R; Gitaí DLG; de Araujo GG
    Scand J Med Sci Sports; 2020 Oct; 30(10):1869-1877. PubMed ID: 32538495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of caffeine on cognitive performance is influenced by CYP1A2 but not ADORA2A genotype, yet neither genotype affects exercise performance in healthy adults.
    Carswell AT; Howland K; Martinez-Gonzalez B; Baron P; Davison G
    Eur J Appl Physiol; 2020 Jul; 120(7):1495-1508. PubMed ID: 32356023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CYP1A2 -163C>A polymorphism does not alter the effects of caffeine on basketball performance.
    Puente C; Abián-Vicén J; Del Coso J; Lara B; Salinero JJ
    PLoS One; 2018; 13(4):e0195943. PubMed ID: 29668752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADOR2A C Allele Carriers Exhibit Ergogenic Responses to Caffeine Supplementation.
    Grgic J; Pickering C; Bishop DJ; Del Coso J; Schoenfeld BJ; Tinsley GM; Pedisic Z
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32168870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Genetics in Moderating the Inter-Individual Differences in the Ergogenicity of Caffeine.
    Southward K; Rutherfurd-Markwick K; Badenhorst C; Ali A
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30248915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine, exercise physiology, and time-trial performance: no effect of
    Glaister M; Chopra K; Pereira De Sena AL; Sternbach C; Morina L; Mavrommatis Y
    Appl Physiol Nutr Metab; 2021 Jun; 46(6):541-551. PubMed ID: 33170731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.
    Guest N; Corey P; Vescovi J; El-Sohemy A
    Med Sci Sports Exerc; 2018 Aug; 50(8):1570-1578. PubMed ID: 29509641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing Matters: Time of Day Impacts the Ergogenic Effects of Caffeine-A Narrative Review.
    Zhang Y; Yang W; Xue Y; Hou D; Chen S; Xu Z; Peng S; Zhao H; Wang C; Liu C
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine, CYP1A2 Genotype, and Exercise Performance: A Systematic Review and Meta-analysis.
    Barreto G; Esteves GP; Marticorena F; Oliveira TN; Grgic J; Saunders B
    Med Sci Sports Exerc; 2024 Feb; 56(2):328-339. PubMed ID: 37844569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International society of sports nutrition position stand: caffeine and exercise performance.
    Guest NS; VanDusseldorp TA; Nelson MT; Grgic J; Schoenfeld BJ; Jenkins NDM; Arent SM; Antonio J; Stout JR; Trexler ET; Smith-Ryan AE; Goldstein ER; Kalman DS; Campbell BI
    J Int Soc Sports Nutr; 2021 Jan; 18(1):1. PubMed ID: 33388079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms in ADORA2A and CYP1A2 Influence Caffeine's Effect on Postprandial Glycaemia.
    Banks NF; Tomko PM; Colquhoun RJ; Muddle TWD; Emerson SR; Jenkins NDM
    Sci Rep; 2019 Jul; 9(1):10532. PubMed ID: 31324842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.